Virtu Financial’s Iovance Biotherapeutics IOVA Stock Holding History

Virtu Financial’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$921K	Sell	221,500 -64,329	-23%	-$244K	0.03%	342
2026 Q1	$1M	Buy	+285,829	New	+$914K	0.04%	308
2025 Q3	–	Sell	-12,555	Closed	-$22K	–	1768
2025 Q2	$22K	Buy	+12,555	New	+$31.2K	﹤0.01%	1245
2025 Q1	–	Sell	-63,276	Closed	-$468K	–	1674
2024 Q4	$468K	Buy	+63,276	New	+$587K	0.02%	527
2024 Q3	–	Sell	-94,099	Closed	-$755K	–	1614
2024 Q2	$755K	Buy	+94,099	New	+$1.01M	0.05%	353
2023 Q3	–	Sell	-21,851	Closed	-$154K	–	1577
2023 Q2	$154K	Buy	+21,851	New	+$156K	0.01%	898
2021 Q2	–	Sell	-42,480	Closed	-$1.34M	–	1772
2021 Q1	$1.34M	Buy	42,480 +35,981	+554%	+$1.49M	0.1%	183
2020 Q4	$302K	Sell	6,499 -12,212	-65%	-$485K	0.03%	639
2020 Q3	$616K	Sell	18,711 -1,120	-6%	-$34.3K	0.11%	233
2020 Q2	$544K	Buy	+19,831	New	+$652K	0.06%	346
2019 Q4	–	Sell	-11,814	Closed	-$215K	–	1627
2019 Q3	$215K	Buy	+11,814	New	+$261K	0.02%	933
2019 Q2	–	Sell	-10,385	Closed	-$99K	–	1640
2019 Q1	$99K	Buy	+10,385	New	+$101K	0.01%	1131
2018 Q4	–	Sell	-60,812	Closed	-$684K	–	1758
2018 Q3	$684K	Buy	+60,812	New	+$863K	0.04%	470
2018 Q1	–	Sell	-22,861	Closed	-$183K	–	2260
2017 Q4	$183K	Buy	+22,861	New	+$184K	0.01%	1723

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Virtu Financial's IOVA Position: Q2 2026 in Review

Virtu Financial reduced its Iovance Biotherapeutics (IOVA) stake by 23% in Q2 2026, selling an estimated $244K and leaving 221,500 shares worth $921K. The position accounts for 0.03% of the portfolio, ranked #342.

Virtu Financial first reported a position in IOVA in Q4 2017 and has held it in 14 quarters since. The position peaked at $1.34M in Q1 2021. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Virtu Financial held 221,500 shares of Iovance Biotherapeutics worth $921K as of Q2 2026.
Virtu Financial sold 64,329 Iovance Biotherapeutics shares in Q2 2026, an estimated $244K.
Iovance Biotherapeutics made up 0.03% of Virtu Financial's portfolio in Q2 2026, its #342 holding.
Virtu Financial first reported a position in Iovance Biotherapeutics in Q4 2017 and has held it in 14 quarters since.
Virtu Financial's Iovance Biotherapeutics position peaked at $1.34M in Q1 2021.
293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.